Fraud and Abuse / Fraud integrity review kept secret

Why This Topic Matters

Understanding the review process helps providers, billing staff, compliance teams, and auditors recognize how suspected fraud matters are evaluated and how related carrier actions may affect practice operations. It also clarifies the broader oversight context involving CMS, the OIG, and other agencies.

Article Sections

1. Fraud integrity review and initial case screening

   Introduces the early stages of a suspected fraud matter and the types of issues that may be resolved without escalation. It also distinguishes fraud review from other review paths at a high level.

2. Expanded investigation and case development

   Describes how a case advances when simple explanations are not sufficient and what investigators may examine next. The section covers internal review activities, involved parties, and related records checks.

3. Patient contact procedures and sampling considerations

   Summarizes the circumstances under which patients may be contacted during an expanded review and the general approach to patient interviews. It also outlines broad sampling considerations used in the review process.

4. Strong potential for fraud and referral reporting

   Explains the point at which a case may be elevated for further referral review and the general contents of the report that accompanies such a referral. It includes the kinds of information investigators may compile for downstream review.

5. Payment suspension and related enforcement actions

   Covers the relationship between fraud referrals and payment suspension activity, along with notice and rebuttal-related handling. It also mentions other enforcement or evidence-preservation actions that may occur.

6. If no strong potential for fraud is found

   Describes the outcome when investigators do not find enough support to continue a fraud case. It notes that the matter is summarized and closed out through internal reporting.